AGEN Agenus Inc.

3.50
-0.06  -2%
Previous Close 3.56
Open 3.57
Price To book 39.56
Market Cap 346.91M
Shares 99,118,000
Volume 529,720
Short Ratio 8.52
Av. Daily Volume 1,016,380

SEC filingsSee all SEC filings

  1. DEF 14A - Other definitive proxy statements 17822245
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 17814039
  3. 8-K - Current report 17812091
  4. 8-K - Current report 17771533
  5. EFFECT - Notice of Effectiveness 17732159

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 initiation announced April 20, 2017.
AGEN2034
Solid tumors
Phase 1/2 trial initiation announced November 30, 2016.
INCAGN1949
Solid tumors - cancer
Phase 1/2 trial commenced June 2016
INCAGN1876
Solid tumors - cancer